Clinical and Experimental Dermatology《临床与实验皮肤病学》(可网站投稿)

Clinical and Experimental Dermatology《临床与实验皮肤病学》(一年8期). Clinical and Experimental Dermatology delivers excellence in dermatology education, it is the British Association of Dermatologists education journal for practicing clinicians and dermatological researchers. It aims to advance the understanding, management and treatment of skin disease and improve patient outcomes and incorporates CPD modules, original articles, reviews and concise reports.

杂志简称:clin exp dermatol
中文译名:《临床与实验皮肤病学》
收录属性:scie(2024版), 目次收录(维普), 目次收录(知网),英文期刊,
自引率:4.70%
投稿方向:医学、dermatology皮肤病学

Clinical and Experimental Dermatology《临床与实验皮肤病学》

SCI/E期刊基本信息

出版周期:年8期 地区:美国
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN 0307-6938;EISSN 1365-2230
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:111 RIVER ST,HOBOKEN,USA,NJ,07030-5774
杂志邮箱:
投稿网址:http://mc.manuscriptcentral.com/ced
杂志官方网址:https://onlinelibrary.wiley.com/journal/13652230
出版商网址:http://www.wiley.com/WileyCDA/

杂志投稿要求

投稿须知【杂志社官方网站信息】

Clinical and Experimental Dermatology

Author Guidelines

Submission and Manuscript Guidelines

Online Submission

All manuscripts should be submitted online through the CED ScholarOne Manuscripts submission system. New users should create an account first. Please avoid creating multiple accounts for the same user. When entering your coauthor details, please check if they already have an account before adding them, as multiple accounts for the same user may result in emails going to the wrong address. Once a user is logged onto the site, submissions should be made via the Author Centre. The system will guide you through the process step by step.

During submission, you must submit the following information:

Author Consent. This section of the submission process must be completed to confirm that all authors listed qualify for authorship according to the ICJME guidelines and that all authors agree to its submission to Clinical and Experimental Dermatology.

Conflicts of interest. This is essential; please see the policies section for complete details.

Funding statement. State sources of funding for the research, including a short description of the involvement of the funder in the study design, data collection, data analysis and manuscript preparation.

Patient Consent. Patient consent for publication, including for use in social media, is required for all case reports and all clinical images whether or not the patient is identifiable. See our patient privacy policy for full details.

Data availability statement. Include a statement of whether the data are available in a publicly available repository.

Publication Criteria

The study has not been published elsewhere except a preprint server or as an abstract for a conference.

Experiments, statistics and other analyses are performed to a high technical standard and are described in sufficient detail to ensure replication of the study.

Conclusions are presented in an appropriate fashion and are supported by the data.

The article is presented in an intelligible fashion and is written in standard English.

The research meets all applicable standards for the ethics of experimentation and research integrity.

The article adheres to appropriate reporting guidelines and community standards for data availability.

Preparation of Manuscripts

General guidance

Manuscript text must be saved in Word (.doc or .docx) or rich text format (.rtf). Tables are considered textual and should be supplied in the same format. Please do not submit text in a PDF format (.pdf).

Figures must be saved as separate figure files. GIF, JPEG, PICT or BMP files are acceptable for submission, but only JPEG, TIFF or EPS files are suitable for printing. After acceptance, you will be contacted to provide print-quality figures if you have not already done so. Please note that if you supply figures in PDF format only, they must be distilled using the ‘print optimized’ option.

Abbreviations must be defined when first used in the abstract and in the main text, as well as when first used in table and figure captions.

All relevant files must be included with each revision of the paper.

Repetition of information or data in different sections of the manuscript must be carefully avoided.

Title page

The first page of all manuscripts should contain the following information:

The title of the paper.

A running head not exceeding 70 characters (not needed for correspondence-type items).

Manuscript word, table and figure counts.

Names of authors as first name(s) followed by surnames. Middle names, if applicable, can be given as initials (e.g. John A. Smith)

Names of the institutions at which the research was conducted, clearly linked to the respective authors using superscript Arabic numbers.

Name and email address of the corresponding author.

A statement of all funding sources that supported the work.

Any conflict of interest disclosures.

Details of ethics approval and informed consent, if applicable.

For Original Articles, bulleted statements (maximum 70 words per answer) in answer to each of the following questions: ‘What is already known about this topic?’ and ‘What does this study add?’

For Review Articles and Concise Reports: up to six learning points, which should be single, short sentences.

Summary

Authors submitting Original Articles should note that structured Summaries (maximum of 250 words) are required. The Summary should adopt the format: Background, Objectives, Methods, Results, Conclusions.

Case Reports and Review Articles require unstructured Summaries (maximum 250 words).

Summaries should contain no reference citations to previously published work.

Correspondence-type items do not require Summaries.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/43617

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午12:01
下一篇 2024年11月9日 下午12:01

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息